Abingdon Health Plc (AIM:ABDX)
London
· Delayed Price · Currency is GBP · Price in GBX 5.75
0.00 (0.00%)
Apr 17, 2025, 4:29 PM GMT+1
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 21.62 million as of April 17, 2025. Its market cap has decreased by -32.29% in one year.
Market Cap
21.62M
Enterprise Value
18.95M
Revenue
6.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.75
Market Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 21.62M, a decrease of -78.59%. That is a compound annual growth rate of -29.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 21.62M | -27.58% |
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | 90.44M | -10.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 159.00B |
| GSK plc | 54.20B |
| Haleon | 34.56B |
| Smith & Nephew | 8.59B |
| ConvaTec Group | 5.18B |
| Hikma Pharmaceuticals | 4.16B |
| HUTCHMED (China) | 1.81B |
| Oxford Nanopore Technologies | 1.12B |